600196 復星醫藥
按盤價 
25.450 +0.800 (+3.245%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.644 | 5.287 | 8.906 | 12.413 | 10.635 |
| 總資產報酬率 ROA (%) | 1.070 | 2.163 | 3.722 | 5.343 | 4.584 |
| 投入資產回報率 ROIC (%) | 1.361 | 2.758 | 4.844 | 6.946 | 5.803 | 邊際利潤分析 |
| 銷售毛利率 (%) | 48.866 | 47.837 | 47.284 | 48.144 | 54.685 |
| 營業利潤率 (%) | 9.428 | 7.989 | 10.595 | 16.156 | 15.578 |
| 息稅前利潤/營業總收入 (%) | 12.315 | 10.263 | 11.881 | 16.679 | 17.825 |
| 淨利潤/營業總收入 (%) | 7.573 | 6.993 | 8.981 | 12.756 | 13.000 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 54.574 | 3.537 | 56.954 | 31.740 | 36.604 |
| 價值變動淨收益/利潤總額(%) | 40.357 | 94.181 | 41.087 | 82.350 | 61.196 |
| 營業外收支淨額/利潤總額(%) | 0.099 | -1.315 | -1.799 | -4.301 | -0.926 | 償債能力分析 |
| 流動比率 (X) | 0.930 | 1.001 | 1.059 | 1.038 | 1.009 |
| 速動比率 (X) | 0.730 | 0.778 | 0.853 | 0.851 | 0.801 |
| 資產負債率 (%) | 49.054 | 50.104 | 49.508 | 48.150 | 45.051 |
| 帶息債務/全部投入資本 (%) | 37.608 | 38.273 | 37.447 | 35.137 | 36.989 |
| 股東權益/帶息債務 (%) | 138.053 | 133.295 | 142.559 | 158.135 | 152.417 |
| 股東權益/負債合計 (%) | 82.870 | 80.355 | 84.031 | 87.243 | 98.127 |
| 利息保障倍數 (X) | 4.280 | 4.317 | 8.066 | 14.022 | 7.459 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 69.520 | 66.226 | 55.771 | 48.883 | 53.051 |
| 存貨周轉天數 (天) | 129.447 | 120.194 | 95.983 | 94.631 | 119.314 |
| 備註： | 即時報價更新時間為 18/10/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
